But the important role of SOX2 in CSC functions has not only been reported in breast cancer; silencing SOX2 in glioblastoma tumour-initiating cells drastically decreases their proliferative and tumourigenic potential [16], and SOX2 controls tumour initiation in squamous cell carcinoma [17]. The gene discussed is SOX2; the disease is breast carcinoma.